Sumatriptan: Price, Dosage & Where to Buy

Sumatriptan is a triptan medicine, a serotonin receptor agonist used for the acute treatment of migraine with or without aura in adults. It treats an established migraine attack rather than preventing future attacks, and the tablet label requires a clear migraine diagnosis before treatment. Sumatriptan requires a prescription in the United Kingdom.

Sumatriptan belongs to the triptan class of medicines. It activates particular serotonin receptors involved in migraine. Serotonin is a chemical messenger that helps nerve cells communicate and also affects blood vessels.

Activating these receptors helps narrow blood vessels around the brain and reduces the release of substances involved in pain signalling from migraine-related nerves. These actions help reduce an ongoing migraine attack. This mechanism is different from preventing attacks from developing in the future.

Sumatriptan tablets are indicated for treating migraine attacks in adults, whether or not the migraine includes aura. Treatment is intended for an attack that is occurring, rather than for preventing future migraine attacks. The label limits use to people with an established, clear diagnosis of migraine.

If the first migraine attack treated does not respond, the label calls for reconsideration of the diagnosis before further attacks are treated. Sumatriptan tablets are not indicated for cluster headache, and their safety and effectiveness for that condition have not been established.

The label lists oral tablets and film-coated tablets in strengths of 25 mg, 50 mg, and 100 mg, alongside nasal spray and subcutaneous injection forms. The label lists a single oral dose of 25 mg, 50 mg, or 100 mg for acute migraine treatment. The label lists consideration of a second dose only if some response to the first dose was observed, with at least 2 hours between doses.

The label lists a maximum oral dose of 200 mg in a 24 hour period. The label lists a maximum single dose of 50 mg for patients with mild to moderate hepatic impairment. The label lists additional tablets up to 100 mg/day if migraine returns after initial sumatriptan injection treatment, with at least 2 hours between tablet doses.

Higher doses may carry a greater risk of adverse reactions. These are label facts for tablets; they do not describe dosing schedules for the nasal spray or injection forms.

The tablet label specifies storage at 20° to 25°C, described as controlled room temperature. Keep the medicine out of the sight and reach of children and follow the storage directions on its packaging.

Sumatriptan tablets are used for an acute migraine attack, rather than on a regular schedule to prevent attacks, so a missed scheduled dose generally does not apply. A forgotten dose should not be made up by doubling a later dose. A pharmacist can clarify how the prescribed treatment plan applies if an attack persists or returns.

Pregnancy registry and observational studies have not detected an increased frequency or consistent pattern of birth defects after sumatriptan exposure. However, registry findings were insufficient for definitive conclusions about overall malformation risk, and animal studies showed developmental harm.

Sumatriptan is excreted in human milk after subcutaneous administration; the label states that milk concentrations following tablet administration are unknown. Discuss treatment during pregnancy or breastfeeding with a doctor or pharmacist.